Holocene Advisors’s BioTelemetry, Inc. BEAT Stock Holding History

Holocene Advisors’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-27,277	Closed	-$1.97M	–	1011
2020 Q4	$1.97M	Buy	27,277 +22,675	+493%	+$1.19M	0.01%	422
2020 Q3	$210K	Sell	4,602 -12,258	-73%	-$512K	﹤0.01%	643
2020 Q2	$762K	Buy	16,860 +9,451	+128%	+$423K	0.01%	464
2020 Q1	$285K	Buy	+7,409	New	+$341K	﹤0.01%	612
2019 Q4	–	Sell	-19,705	Closed	-$803K	–	813
2019 Q3	$803K	Buy	+19,705	New	+$851K	0.01%	531

Other funds holding BEAT

LCM

Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

Holocene Advisors's BEAT Position: Q1 2021 in Review

Holocene Advisors sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 27,277 shares — an estimated $1.97M sold.

Holocene Advisors first reported a position in BEAT in Q3 2019 and held it in 5 quarters. The position peaked at $1.97M in Q4 2020. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

Holocene Advisors reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
Holocene Advisors sold 27,277 BioTelemetry, Inc. shares in Q1 2021, an estimated $1.97M.
Holocene Advisors first reported a position in BioTelemetry, Inc. in Q3 2019 and held it in 5 quarters.
Holocene Advisors's BioTelemetry, Inc. position peaked at $1.97M in Q4 2020.
1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on Holocene Advisors's 13F filing for Q1 2021, filed 17 May 2021.